Literature DB >> 24224681

The current status of bridging anticoagulation.

Jignesh P Patel1, Roopen Arya.   

Abstract

For patients prescribed chronic vitamin K antagonist therapy requiring a surgical or invasive procedure, the question of whether or not to bridge and how to bridge is commonly encountered in clinical practice. Bridging anticoagulation has evolved over the years and the evidence base for current practice is deficient in many areas. Clinical trials currently being completed with conventional anticoagulants should help strengthen the evidence base for future practice. The availability of novel oral anticoagulants is a welcome addition, though their optimal management peri-procedure is yet to be determined. Prospective multi-centre controlled studies that can provide the evidence base for novel oral anticoagulant peri-procedural management are required.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  anticoagulation; bridging; low molecular weight heparin; surgical procedures; vitamin K antagonist therapy

Mesh:

Substances:

Year:  2013        PMID: 24224681     DOI: 10.1111/bjh.12644

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Use of dabigatran vs. warfarin with low-molecular-weight heparin bridging in catheter ablation for atrial fibrillation patients with a low CHADS2 score.

Authors:  Li Hao; Bing Rong; Fei Xie; Ming-Jie Lin; Jing-Quan Zhong
Journal:  Biomed Rep       Date:  2017-03-28

2.  Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.

Authors:  James D Douketis; Alex C Spyropoulos; Scott Kaatz; Richard C Becker; Joseph A Caprini; Andrew S Dunn; David A Garcia; Alan Jacobson; Amir K Jaffer; David F Kong; Sam Schulman; Alexander G G Turpie; Vic Hasselblad; Thomas L Ortel
Journal:  N Engl J Med       Date:  2015-06-22       Impact factor: 91.245

Review 3.  [Platelet aggregation inhibitors and anticoagulants during ophthalmic interventions].

Authors:  N Feltgen; H Hoerauf; W Noske; A Hager; J Koscielny
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

Review 4.  Management of non-vitamin K antagonist oral anticoagulants in the perioperative setting.

Authors:  Anne-Sophie Dincq; Sarah Lessire; Jonathan Douxfils; Jean-Michel Dogné; Maximilien Gourdin; François Mullier
Journal:  Biomed Res Int       Date:  2014-09-03       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.